New study boosts COVID-19 testing for diabetics in georgia
NCT ID NCT06141850
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at ways to encourage COVID-19 testing and prevention habits among people with diabetes or at risk for it. About 290 participants in Georgia were split into two groups to compare the effects of a 16-week program. The goal was to see if the program increased testing and vaccination rates.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Emory University
Atlanta, Georgia, 30322, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?